NGNE — NEUROGENE INC
As of Q2 2026, 29 SEC-registered investment managers reported holding NGNE (NEUROGENE INC) in their latest 13F filings, with a combined reported value of $185.37M across 5.90M shares. That is +10.3% by share count (+549.53K shares) versus the previous quarter, while reported value moved +71.8%. Ownership is concentrated: the five largest holders account for 70.5% of reported value and the top ten for 87.5%.
Compared with the prior quarter, 8 opened new positions, 13 added to existing stakes, 7 trimmed, 1 exited entirely. 13F holdings are quarter-end snapshots, so these moves reflect positioning as of Q2 2026, not real-time trading.
NGNE is classified in the Health Care sector.
All figures on this page are computed from SEC Form 13F quarterly filings. 13F filers disclose long positions of $100,000 or more within 45 days of quarter end; short positions, options overlays and intra-quarter trades are not included, so treat the numbers as a quarterly snapshot of institutional ownership rather than real-time positioning.
| Fund | Quarter | Shares | Value | Portfolio Weight | Change |
|---|---|---|---|---|---|
| Casdin Capital history | Q2 2026 | 1.55M | $48.60M | 2.43% | Add |
| BlackRock Inc history | Q2 2026 | 1.06M | $33.27M | 0.00% | Add |
| Janus Henderson Group history | Q3 2024 | 709.47K | $29.78M | 0.01% | Reduce |
| Balyasny Asset Management history | Q2 2026 | 818.71K | $25.75M | 0.03% | Add |
| Citadel Advisors history | Q2 2026 | 435.68K | $13.70M | 0.00% | Add |
| Vanguard Group history | Q4 2025 | 656.57K | $13.53M | 0.00% | Add |
| Fidelity Management & Research (FMR) history | Q2 2026 | 295.56K | $9.30M | 0.00% | Reduce |
| Geode Capital Management history | Q2 2026 | 293.18K | $9.22M | 0.00% | Add |
| Franklin Resources history | Q2 2026 | 204.28K | $6.42M | 0.00% | New |
| Morgan Stanley history | Q2 2026 | 191.72K | $6.03M | 0.00% | Reduce |
| UBS Group AG history | Q2 2026 | 171.29K | $5.39M | 0.00% | Reduce |
| Point72 Asset Management history | Q2 2026 | 141.92K | $4.46M | 0.01% | New |
| Moore Capital Management history | Q2 2026 | 141.64K | $4.45M | 0.07% | New |
| Deutsche Bank AG history | Q2 2026 | 106.66K | $3.35M | 0.00% | Hold |
| Northern Trust Corp history | Q2 2026 | 103.64K | $3.26M | 0.00% | Add |
| Goldman Sachs Group history | Q2 2026 | 101.28K | $3.19M | 0.00% | Reduce |
| JPMorgan Chase & Co history | Q2 2026 | 61.88K | $2.00M | 0.00% | New |
| Millennium Management history | Q2 2026 | 42.73K | $1.34M | 0.00% | Reduce |
| Charles Schwab Investment Management history | Q2 2026 | 32.74K | $1.03M | 0.00% | Add |
| Wellington Management Group history | Q2 2026 | 31.39K | $987.31K | 0.00% | New |
New Positions (Q2 2026)
- Franklin Resources 204.28K sh · $6.42M
- Point72 Asset Management 141.92K sh · $4.46M
- Moore Capital Management 141.64K sh · $4.45M
- JPMorgan Chase & Co 61.88K sh · $2.00M
- Wellington Management Group 31.39K sh · $987.31K
- D. E. Shaw & Co 9.78K sh · $307.61K
- Invesco Ltd 6.66K sh · $209.40K
- T. Rowe Price Associates 8.90K sh · $280
Fully Exited (vs previous quarter)
- Two Sigma Investments sold 13.89K sh · $280.04K
Fund Position History — shares by quarter (top 20 funds)
| Fund | Q4 2023 | Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | Q1 2026 | Q2 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Casdin Capital | 524.62K | 524.62K | 524.62K | 524.62K | 1.30M | 1.30M | 1.30M | 1.30M | 1.30M | 1.42M | 1.55M |
| BlackRock Inc | — | — | — | 1.37M | 1.52M | 1.40M | 977.68K | 951.10K | 945.58K | 1.01M | 1.06M |
| Balyasny Asset Management | — | — | — | — | — | — | — | 699.00K | 608.58K | 718.39K | 818.71K |
| Citadel Advisors | — | — | — | — | 69.70K | 67.02K | — | — | 364.23K | 413.23K | 435.68K |
| Fidelity Management & Research (FMR) | — | — | 72.29K | 731.80K | 860.33K | 462.88K | 468.48K | 115.55K | 130.33K | 382.65K | 295.56K |
| Geode Capital Management | 15.72K | 99.31K | 222.06K | 220.60K | 234.62K | 259.38K | 247.78K | 246.43K | 249.69K | 279.00K | 293.18K |
| Franklin Resources | — | — | — | 7.05K | — | — | — | — | — | — | 204.28K |
| Morgan Stanley | 339.98K | 516.61K | 382.67K | 356.43K | 329.86K | 286.11K | 545.60K | 426.58K | 371.17K | 285.24K | 191.72K |
| UBS Group AG | 1.00K | 9.72K | 3.42K | 5.12K | 347.20K | 208.72K | 240.32K | 227.72K | 154.12K | 185.68K | 171.29K |
| Point72 Asset Management | — | 28.03K | — | — | — | 200.00K | — | 7.67K | — | — | 141.92K |
| Moore Capital Management | — | — | — | — | — | — | — | — | — | — | 141.64K |
| Deutsche Bank AG | — | 87.14K | 332.28K | 334.37K | 152.37K | 150.86K | 151.12K | 152.28K | 85.57K | 106.25K | 106.66K |
| Northern Trust Corp | — | 22.64K | 28.74K | 94.72K | 100.57K | 110.41K | 93.17K | 90.10K | 85.56K | 97.62K | 103.64K |
| Goldman Sachs Group | — | 74.09K | 13.05K | 41.16K | 38.06K | 21.18K | 17.30K | 72.80K | 162.02K | 107.71K | 101.28K |
| JPMorgan Chase & Co | 10 | 10 | 4.40K | 4.58K | 481.00K | 86.98K | 6.33K | 5.56K | 5.36K | — | 61.88K |
| Millennium Management | — | 83.42K | 24.74K | 43.70K | — | 157.94K | 307.81K | 247.86K | 71.32K | 204.81K | 42.73K |
| Charles Schwab Investment Management | — | 5.24K | 29.58K | 30.32K | 30.32K | 33.97K | 29.96K | 29.96K | 29.96K | 30.06K | 32.74K |
| Wellington Management Group | — | — | — | 18.29K | 21.72K | 34.42K | 44.90K | — | — | — | 31.39K |
| BNY Mellon | — | — | 30.43K | 22.67K | 22.60K | 24.45K | 23.76K | 24.65K | 23.09K | 26.04K | 28.74K |
| Renaissance Technologies | 50.19K | 58.71K | 52.81K | 22.81K | — | — | — | — | 14.00K | 43.40K | 20.41K |
▲ Bought Low (fund opened/added, stock rose ≥5% next quarter) ▼ Sold High (fund reduced, stock fell ≥5% next quarter)
Drag / scroll to zoom · Default shows the most recent year · Annotations come from quarterly fund actions in 13F filings · Hover a marker for details